Posts Archive for April 2010

Does Stress prolong life?

Apr.11, 2010

British researchers found that nervousness, frustration, quarrels help to live longer and stay beautiful and cheerful. They refute the earlier statement that all this leads to premature aging and different diseases. In addition the scientists found that stress can be a good prevention from diseases of the joints, blood vessels and heart.One of the famous London’s scientist Marios Kiriazis is actively engaged in the investigation.

Diabetes treatment with Avandamet

Apr.11, 2010

The diabetes is considered to be one of the most important medico-social problems in nowadays. Type II Diabetes continues to grow, and it is anticipated that within the nearest 5 years number of patients of type II will rich 3% from all population of the Earth.

Diabetes – is a  chronic and worldwide spread disease, that is accompanied by carbohudrate, lipoid and protein exchange derangements and leads to the development of different complications of the cardiovascular system, kidney, eyes and peripheral nervous system.

Claritin is a gentle suggestion for allergy relief

Apr.11, 2010

Claritin is used over 20 years. The manufacturer of the medication is worldwide known pharmaceutical company called Shering-Plough.

Claritin is the most prescribed allergy drug in the world and one of the modern antiallergic drugs which has the ability to treat such allergy symptoms as: sneezing, itching and nasal discharge, epiphora, iredness and itching in the eyes, throat discomfort. Besides, claritin is widely used in sting allergy. High efficiency of claritin allows successfully to use the drug in the complex treatment of different skin diseases which are causing  the itch (atopic dermatit, contact dermati, chronic eczema)

Evista – drug for breast cancer prevention.

Apr.11, 2010

Study: Can the drug for osteoporosis treatment prevent breast cancer in high-risk group?

Evista has advantages for women of increased risk group during menopause. Results of a large, national studies have shown that Evista is equivalent to other well-recognized preventive means – tamoxifen in order to prevent breast cancer among women at increased risk during menopause. Moreover, Evista as it turned out, has less side effects in view of uterine cancer and clotting problems, comparing with women who administer tamoxifen.